Version 2 2024-06-17, 09:07Version 2 2024-06-17, 09:07
Version 1 2014-10-28, 10:27Version 1 2014-10-28, 10:27
journal contribution
posted on 2024-06-17, 09:07authored byT Dunning, K Cukier
Glycated haemoglobin (HbA1c) reflects the average blood glucose level in the three months preceding the test. Changes in consecutive HbA1c tests indicate deteriorating, or improved, glycaemic control. HbA1c is considered to be the "gold standard" measure of blood glucose control and is often used as the basis for prescribing choices and other care decisions. A number of factors can affect the accuracy of the HbA1c result, for example, the life span of red blood cells, assay methods and clinicians' awareness of possible interfering factors. The aim of this article is to outline how HbA1c is used as a diagnostic test, how it is used to monitor glycaemic control and how it can guide management decisions. It is also important to emphasise the importance of considering HbA1c in the context of the individual rather than as an isolated number.